组学技术在变应性鼻炎发病机制中的研究进展
DOI:
作者:
作者单位:

1.广东医科大学第一临床医学院;2.南方医科大学珠江医院耳鼻咽喉头颈外科中心

作者简介:

通讯作者:

基金项目:

广东省医学会临床科研专项基金重点项目(NO:2024HY-B2012)


Research progress of omics technologies in the pathogenesis of allergic rhinitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    变应性鼻炎(Allergic Rhinitis,AR)是一种常见的过敏性疾病,其发病机制复杂,涉及多种遗传因素、蛋白质的调控及环境因素的共同作用。近年来,组学技术的广泛应用,如基因组学、转录组学、蛋白质组学和代谢组学等,极大地推动了我们对AR发病机制的理解。本综述总结了多个组学技术在AR研究中的最新进展,基因组学研究揭示了多个与AR相关的风险基因位点,转录组学分析强调了差异表达基因及其调控网络在AR中的作用。而蛋白质组学和代谢组学的研究为发现新型生物标志物的识别及潜在治疗靶点的发现提供了重要支持。本文还提出了多组学整合分析在AR精准医学中的潜力,未来研究方向应集中在数据整合与应用转化方面,以进一步推动AR的诊断和治疗。

    Abstract:

    Allergic rhinitis (AR) is a common allergic disease with a complex pathogenesis involving various genetic factors, protein regulation, and environmental influences. In recent years, the widespread application of omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, has greatly advanced our understanding of the pathogenesis of AR. This review summarizes the latest progress of various omics technologies in AR research, where genomic studies have revealed multiple risk gene loci associated with AR, and transcriptomic analyses have emphasized the role of differentially expressed genes and their regulatory networks in AR. Additionally, proteomics and metabolomics research has provided significant support for the identification of novel biomarkers and potential therapeutic targets. This article also discusses the potential of multi-omics integrative analysis in the precision medicine of AR, suggesting that future research should focus on data integration and application transformation to further advance the diagnosis and treatment of AR.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2024-10-18
  • 最后修改日期:2025-01-14
  • 录用日期:2025-01-15
  • 在线发布日期:
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭